BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35919081)

  • 1. Trends in the Prevalence and Incidence of Opium Abuse and its Association with Coronary Artery Risk Factors in Adult Population in Iran: Findings from Kerman Coronary Artery Disease Risk Factors Study.
    Najafipour H; Masoumi M; Amirzadeh R; Rostamzadeh F; Foad R; Shadkam Farrokhi M
    Iran J Med Sci; 2022 Jul; 47(4):328-337. PubMed ID: 35919081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opium as a risk factor for early-onset coronary artery disease: Results from the Milano-Iran (MIran) study.
    Maino A; Sadeghian S; Mancini I; Abbasi SH; Poorhosseini H; Boroumand MA; Lotfi-Tokaldany M; Jalali A; Pagliari MT; Rosendaal FR; Peyvandi F
    PLoS One; 2023; 18(4):e0283707. PubMed ID: 37074987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opium consumption in men and diabetes mellitus in women are the most important risk factors of premature coronary artery disease in Iran.
    Sadeghian S; Graili P; Salarifar M; Karimi AA; Darvish S; Abbasi SH
    Int J Cardiol; 2010 May; 141(1):116-8. PubMed ID: 19346018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of opium consumption on coronary artery disease risk factors and oral health: Results of Kerman Coronary Artery Disease Risk factors Study a population-based survey on 5900 subjects aged 15-75 years.
    Najafipour H; Masoomi M; Shahesmaeili A; Haghdoost AA; Afshari M; Nasri HR; Kahnooji M; Samadi S; Mirzazadeh A
    Int J Prev Med; 2015; 6():42. PubMed ID: 26097671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of persistent opium consumption after surgery on the long-term outcomes of surgical revascularisation.
    Masoudkabir F; Yavari N; Pashang M; Sadeghian S; Jalali A; Poorhosseini H; Tafti SHA; Bagheri J; Abbasi K; Omran AS; Mansourian S; Momtahan S; Mortazavi SH; Karimi A
    Eur J Prev Cardiol; 2020 Dec; 27(18):1996-2003. PubMed ID: 32673508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the prevalence and incidence of anxiety and depressive symptoms in Iran: findings from KERCADRS.
    Najafipour H; Shahrokhabadi MS; Banivaheb G; Sabahi A; Shadkam M; Mirzazadeh A
    Fam Med Community Health; 2021 Jul; 9(3):. PubMed ID: 34215671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prevalence and 5-Year Incidence Rate of Low Physical Activity in an Urban Population of 10,000 in Southeastern Iran: Relationship With Other Cardiovascular Risk Factors.
    Najafipour H; Kahnooji M; Baneshi MR; Yeganeh M; Ahmadi Gohari M; Shadkam Farokhi M; Mirzazadeh A
    J Phys Act Health; 2020 Apr; 17(4):435-442. PubMed ID: 32109881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opium consumption and coronary atherosclerosis in diabetic patients: a propensity score-matched study.
    Hosseini SK; Masoudkabir F; Vasheghani-Farahani A; Alipour-Parsa S; Sheikh Fathollahi M; Rahimi-Foroushani A; Hakki E; Goodarzynejad H; Eftekhar H
    Planta Med; 2011 Nov; 77(17):1870-5. PubMed ID: 21800277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of anxiety and depression symptoms and their relationship with other coronary artery disease risk factors: A population-based study on 5900 residents in Southeast Iran.
    Najafipour H; Banivaheb G; Sabahi A; Naderi N; Nasirian M; Mirzazadeh A
    Asian J Psychiatr; 2016 Apr; 20():55-60. PubMed ID: 27025473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Incidence Rate of Diabetes, Pre-diabetes, Uncontrolled Diabetes, and Their Predictors in the Adult Population in Southeastern Iran: Findings From KERCADR Study.
    Najafipour H; Farjami M; Sanjari M; Amirzadeh R; Shadkam Farokhi M; Mirzazadeh A
    Front Public Health; 2021; 9():611652. PubMed ID: 34790639
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes and its predictors in general population aged 15 to 75 years: A community-based study (KERCADRS) in southeastern Iran.
    Najafipour H; Sanjari M; Shokoohi M; Haghdoost AA; Afshari M; Shadkam M; Etemad K; Mirzazade A
    J Diabetes; 2015 Sep; 7(5):613-21. PubMed ID: 25042896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological update on prevalence and incidence of overweight and obesity in adults in the south-east of the Islamic Republic of Iran: findings from the Kerman Coronary Artery Diseases Risk Factors Study (KERCADRS).
    Najafipour H; Bagheri M; Saberi S; Farokhi M; Amirzadeh R; Mirzazadeh A
    East Mediterr Health J; 2021 Sep; 27(9):874-883. PubMed ID: 34569042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opium decreases the age at myocardial infarction and sudden cardiac death: a long- and short-term outcome evaluation.
    Roohafza H; Talaei M; Sadeghi M; Haghani P; Shokouh P; Sarrafzadegan N
    Arch Iran Med; 2013 Mar; 16(3):154-60. PubMed ID: 23432167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance use among Iranian cardiac surgery patients and its effects on short-term outcome.
    Azarasa M; Azarfarin R; Changizi A; Alizadehasl A
    Anesth Analg; 2009 Nov; 109(5):1553-9. PubMed ID: 19843794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and trend of multiple coronary artery disease risk factors and their 5-year incidence rate among adult population of Kerman: results from KERCADR study.
    Zeinali-Nezhad N; Najafipour H; Shadkam M; Pourhamidi R
    BMC Public Health; 2024 Jan; 24(1):25. PubMed ID: 38166891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking Water-Pipe, Opium Use and Prevalence of Heart Disease: A Cross-sectional Analysis of Baseline Data from the Pars Cohort Study, Southern Iran.
    Adib A; Masoompour SM; Molavi Vardanjani H; Gondomkar A; Poustchi H; Salehi A; Islami F; Malekzadeh R
    Arch Iran Med; 2020 May; 23(5):289-295. PubMed ID: 32383612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the association between opium abuse, blood lead levels, and the complexity of coronary artery disease.
    Khameneh Bagheri R; Mousavi SH; Mehrad-Majd H; Jamili MJ; Nasimi Shad A; Baradaran Rahimi V
    Physiol Rep; 2024 Mar; 12(5):e15975. PubMed ID: 38480374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can opium abuse be a risk factor for carotid stenosis in patients who are candidates for coronary artery bypass grafting?
    Shirani S; Shakiba M; Soleymanzadeh M; Esfandbod M
    Cardiol J; 2010; 17(3):254-8. PubMed ID: 20535715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Incident Type 2 Diabetes and Opium Use: Mediation by Body Mass and Adiposity.
    Nalini M; Poustchi H; Roshandel G; Kamangar F; Khoshnia M; Gharavi A; Brennan P; Boffetta P; Dawsey SM; Abnet CC; Malekzadeh R; Etemadi A
    Am J Epidemiol; 2023 Nov; 192(12):2050-2062. PubMed ID: 37552966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Health Determinants among Opium Users in Kerman, Iran.
    Nekouei AH; Kakooei S; Najafipour H; Kakoei S
    Addict Health; 2021 Jul; 13(3):156-164. PubMed ID: 35140894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.